0.4598
price up icon1.73%   0.0078
after-market Handel nachbörslich: .46 0.0002 +0.04%
loading

Vaxart Inc Aktie (VXRT) Neueste Nachrichten

pulisher
Jun 13, 2025

Vaxart Announces Preliminary Results of Annual Meeting of Stockh - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Vaxart, Inc. Announces Results from 2025 Annual Meeting of Stockholders - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Vaxart Faces Nasdaq Challenge as Shareholders Block Reverse Split Proposal at Annual Meeting - Stock Titan

Jun 13, 2025
pulisher
Jun 12, 2025

Vaxart reports improved antibody response in norovirus vaccine trial By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 11, 2025

Biotech Steals The Mid-Week Spotlight With Key Announcement - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart (VXRT) Unveils Promising Phase 1 Results for New Noroviru - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discu - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart Jumps 38% After Positive Norovirus Trial - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart soars on positive data from new norovirus vaccine trial - MSN

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart (VXRT) Shares Soar After Promising Norovirus Vaccine Tria - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart, DoubleVerify, Cracker Barrel - TradingView

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart stock soars after positive Phase 1 norovirus vaccine results By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart's Oral Norovirus Vaccine Pills Meet Primary Immunological Endpoint in Phase 1 Trial - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Sector Update: Health Care Stocks Higher Pre-Bell Wednesday - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart stock soars after positive Phase 1 norovirus vaccine results - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart reports improved antibody response in norovirus vaccine trial - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart Reports Positive Clinical Data Demonstrating that its Sec - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart Reports Positive Clinical Data Demonstrating Second-Generation Vaccine Technology Produces Stronger Antibody Responses Than First-Generation - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Vaxart Reports Positive Clinical Data Demonstrating that - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Breakthrough: New Oral Pill Vaccine Technology Delivers 141% Stronger Immune Response Against Norovirus - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Vaxart to Reveal First-Ever Oral Norovirus Vaccine Trial Results: Key Data Coming Tomorrow - Stock Titan

Jun 10, 2025
pulisher
Jun 06, 2025

Vaxart, Inc. (NASDAQ:VXRT) Shares Bought by Squarepoint Ops LLC - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 | VXRT Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Vaxart, Inc. (NASDAQ:VXRT) Sees Significant Increase in Short Interest - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart - Business Wire

Jun 03, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Decreases Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Vaxart Announces Adjournment of Annual Meeting of Stockholders | - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Vaxart Announces Adjournment Of Annual Meeting Of Stockholders - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Vaxart Announces Adjournment of Annual Meeting of Stockholders | VXRT Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Vaxart Annual Meeting Adjourned to June 13, 2025; Proxy Advisory Firms Support Proposal No. 2 - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Vaxart Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

B. Riley Has Positive Forecast for Vaxart Q3 Earnings - Defense World

Jun 02, 2025
pulisher
May 31, 2025

FY2029 Earnings Estimate for Vaxart Issued By B. Riley - Defense World

May 31, 2025
pulisher
May 31, 2025

Vaxart stock climbs on positive study of pill-based norovirus vaccine - MSN

May 31, 2025
pulisher
May 30, 2025

Zoom Rises 8% in 3 Months: Here's Why You Should Buy the Stock Now - The Globe and Mail

May 30, 2025
pulisher
May 30, 2025

Vaxart seeks shareholder nod for reverse stock split By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 - The Manila Times

May 29, 2025
pulisher
May 29, 2025

Vaxart Leaders Set for Key Fireside Chat at Major Healthcare Conference: What to Expect - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Vaxart (VXRT) Releases Video Update Urging Support for Reverse S - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Vaxart seeks shareholder nod for reverse stock split - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders | VXRT Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Vaxart Founder Makes Urgent Appeal: Critical Nasdaq Compliance Vote Deadline Approaches - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Vaxart Discusses Reverse Stock Split and Capital Raise - TipRanks

May 28, 2025
pulisher
May 28, 2025

Vaxart Answers Additional Frequently Asked Questions from Retail Investors - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Mee - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Vaxart Begins Phase 2b Trial for Oral COVID-19 Vaccine - TipRanks

May 28, 2025
pulisher
May 28, 2025

Vaxart (VXRT) Addresses Stockholder Concerns Ahead of Annual Meeting | VXRT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Vaxart Reveals New Split Ratio Details as Nasdaq Delisting Deadline LoomsCEO Urges Action - Stock Titan

May 28, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):